Also in 2019 the SEC was making the S-3's effective so they could sell shares to the public. Not any more, and this is the real killer. How much longer will accredited private investors fund $1M here and there to see the share price crater?
The soon to be released quarterly filing will fully reveal the even more desperate financial condition of CYDY as compared the the last 10q.
The present condition is definitely more dire than 2019. Upside is severely diminished due to the requirement to partner on EVERYTHING GOING FORWARD AND POOR BARGAINING POSITION. That of course assumes the can hold off BK.
The CoVID pursuit made a lot of people rich but killed the company and many retail investors who unfortunately bought Naders lies “all in”. CoVID IS OVER For CYDY. 17 critical enrolled in 6 months. There will be no commercially viable use of this product for CoVID.
Market Data 
Markets 
